Edition:
United States

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

824.50GBp
20 Nov 2018
Change (% chg)

209.50 (+34.06%)
Prev Close
615.00
Open
609.50
Day's High
832.00
Day's Low
609.00
Volume
36,279,499
Avg. Vol
1,053,785
52-wk High
832.00
52-wk Low
467.40

Chart for

About

BTG plc is medical device development and healthcare service provider. It provides Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care and licensing business. It operates through three segments: Interventional Medicine, Pharmaceuticals and Licensing. The... (more)

Overall

Beta: 0.11
Market Cap(Mil.): £2,754.76
Shares Outstanding(Mil.): 386.36
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 82.78 31.23 33.59
EPS (TTM): 0.09 -- --
ROI: 3.10 15.57 15.05
ROE: 3.68 16.94 16.62

Deals of the day-Mergers and acquisitions

Nov 20 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

4:00pm EST

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 20 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn bridge loan from Barclays Bank.

1:21pm EST

Boston Scientific builds medical technology with $4.2 billion BTG deal

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

7:14am EST

UPDATE 2-Boston Scientific builds medical tech with $4.2 billion BTG deal

* U.S. group's biggest deal since 2006 Guidant acquisition (Adds latest shares, analyst comment, further details)

7:08am EST

Boston Scientific offers to buy UK's BTG for about $4.24 billion

Nov 20 U.S. medical device maker Boston Scientific Corp said it offered to buy British pharmaceutical firm BTG Plc for about 3.3 billion pounds ($4.24 billion) in cash.

4:05am EST

Brexit, trade progress drive European stocks up after tech rout

LONDON European shares recovered on Tuesday as hopes for an easing of the Sino-U.S. trade war and an imminent Brexit deal chased away the previous session's fears of a peak in tech stocks.

Nov 13 2018

PRESS DIGEST- British Business - Nov 13

Nov 13 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Nov 12 2018

BTG Pharma upgrades sales guidance after strong first half

LONDON, Oct 4 British pharmaceutical firm BTG upgraded its sales forecast on Thursday after it included its varicose vein treatment Varithena in its oncology and vascular portfolio and saw strong demand for its tumour-targeting medicines.

Oct 04 2018

Deals of the day-Mergers and acquisitions

Sept 7 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Sep 07 2018

British healthcare firm BTG buys Irish vascular device maker

British healthcare company BTG Plc has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

Sep 07 2018

Earnings vs. Estimates